Taken together, this in silico analysis of the MTC-GBM subtype revealing upregulation of antioxidant genes, especially SOD1, and the GPM-GBM subtype showing upregulation of SOD2 and TLR4 pathway-related genes, mirrors the findings observed for A172 and U87MG cells, respectively. This evidence concerns the gene SOD2 and glioblastoma.